|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.800 CNY | +0.84% |
|
0.00% | -13.20% |
| 25/05 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 24/04 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 823.55Cr 121.63Cr 106.88Cr 100Cr 92Cr 171.38Cr 12TCr 175.61Cr 1.18TCr 462.63Cr 5.76TCr 456.66Cr 446.74Cr 20TCr | P/E 2024 |
69.9x | P/E 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.79TCr 264.5Cr 232.42Cr 216.94Cr 199.1Cr 372.7Cr 25TCr 381.89Cr 2.57TCr 1.01TCr 13TCr 993.07Cr 971.51Cr 43TCr | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.58% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | +0.84% | ||
| Current month | +12.41% | ||
| 1 month | +14.29% | ||
| 3 months | -8.57% | ||
| 6 months | -16.08% | ||
| Current year | -13.20% |
| 1 week | 4.65 |  | 4.83 |
| 1 month | 4.21 | | 5.08 |
| Current year | 4.11 | | 6.07 |
| 1 year | 4.11 | | 7.46 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
Ya Lou Wang
BRD | Director/Board Member | 54 | 12/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/02/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.84% | 0.00% | -30.33% | -16.81% | 120.65Cr | |
| -0.87% | +4.04% | +58.60% | +166.20% | 1,08900Cr | |
| -0.45% | +3.87% | +57.95% | +58.50% | 64TCr | |
| +0.04% | +3.95% | +37.69% | +76.03% | 47TCr | |
| -1.69% | +8.36% | +38.80% | +34.26% | 36TCr | |
| -0.51% | +3.35% | +39.00% | +43.76% | 30TCr | |
| +1.50% | +5.14% | +21.72% | +18.77% | 27TCr | |
| +0.79% | +4.32% | -25.07% | -36.02% | 23TCr | |
| -1.39% | +5.90% | +27.70% | +65.55% | 21TCr | |
| -1.18% | +1.83% | +16.20% | +74.32% | 17TCr | |
| Average | -0.23% | +4.53% | +24.22% | +48.46% | 37.32TCr | |
| Weighted average by Cap. | -0.48% | +5.14% | +40.99% | +81.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 986.96Cr 145.76Cr 128.08Cr 119.55Cr 109.72Cr 205.39Cr 14TCr 210.45Cr 1.42TCr 554.42Cr 6.91TCr 547.27Cr 535.39Cr 24TCr | 924.17Cr 136.49Cr 119.93Cr 111.95Cr 102.74Cr 192.32Cr 13TCr 197.06Cr 1.33TCr 519.15Cr 6.47TCr 512.45Cr 501.32Cr 22TCr |
| Net income | 13Cr 1.88Cr 1.65Cr 1.54Cr 1.41Cr 2.64Cr 179.65Cr 2.71Cr 18Cr 7.13Cr 89Cr 7.04Cr 6.89Cr 307.31Cr | 18Cr 2.7Cr 2.38Cr 2.22Cr 2.04Cr 3.81Cr 258.95Cr 3.9Cr 26Cr 10Cr 128.14Cr 10Cr 9.93Cr 442.98Cr |
| Net Debt | 978.97Cr 144.58Cr 127.04Cr 118.59Cr 108.83Cr 203.73Cr 14TCr 208.75Cr 1.41TCr 549.93Cr 6.85TCr 542.83Cr 531.05Cr 24TCr | 967.38Cr 142.87Cr 125.54Cr 117.18Cr 107.54Cr 201.31Cr 14TCr 206.28Cr 1.39TCr 543.43Cr 6.77TCr 536.41Cr 524.77Cr 23TCr |
Employees
9,972
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | CN¥4.800 | +0.84% | 1,52,25,700 |
| 28/26/28 | CN¥4.760 | -0.21% | 1,30,80,500 |
| 27/26/27 | CN¥4.770 | +2.14% | 1,63,76,630 |
| 24/26/24 | CN¥4.670 | -3.11% | 1,62,02,500 |
| 23/26/23 | CN¥4.820 | +0.21% | 2,06,49,623 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Select your edition
All financial news and data tailored to specific country editions
